Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study
2019 · Nature Medicine · 2,084 citations
https://doi.org/10.1038/s41591-019-0495-2
M
Michel P. Hermans
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
345
Papers
12.9K
Citations
44
h-index
119
i10-index
Michel P. Hermans is an academic researcher from Cliniques Universitaires Saint-Luc. The author has contributed to research in topics: Diabetes, Cardiovascular Risks, and Lipoproteins & Diabetes Treatment and Management & Diabetes Management and Research. The author has an h-index of 44, co-authored 294 publications.
ORCID: 0000-0002-1647-9031Papers by this author
worksA purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice
2016 · Nature Medicine · 1,997 citations
https://doi.org/10.1038/nm.4236
<i>Dysosmobacter welbionis</i> is a newly isolated human commensal bacterium preventing diet-induced obesity and metabolic disorders in mice
2021 · Gut · 207 citations
https://doi.org/10.1136/gutjnl-2020-323778
Residual macrovascular risk in 2013: what have we learned?
2014 · Cardiovascular Diabetology · 169 citations
https://doi.org/10.1186/1475-2840-13-26
Clinical Characteristics and Outcomes of Patients Hospitalized for COVID-19 in Africa: Early Insights from the Democratic Republic of the Congo
2020 · American Journal of Tropical Medicine and Hygiene · 118 citations
https://doi.org/10.4269/ajtmh.20-1240
Non-HDL-cholesterol as valid surrogate to apolipoprotein B100 measurement in diabetes: Discriminant Ratio and unbiased equivalence
2011 · Cardiovascular Diabetology · 81 citations
https://doi.org/10.1186/1475-2840-10-20
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat